Humacyte director reports 156,519 shares held directly
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
Humacyte, Inc. director Paul Brian Kuznik reported 156,519 shares of common stock held directly and 65,719 shares held by his spouse, as of September 22, 2026.
Insider Trade Summary
Holdings reported, no transactions
Holdings
Insider
Kuznik Paul Brian
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
Holdings:
Common Stock — 65,719 shares (Indirect, By spouse);
Common Stock — 156,519 shares (Direct)
Key Figures
Common shares held directly: 156,519 shares
Common shares held by spouse: 65,719 shares
2 metrics
Common shares held directly
156,519 shares
Reported September 22, 2026
Common shares held by spouse
65,719 shares
Reported September 22, 2026
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.